Qilian International Holding Group Limited (QLI)
| Market Cap | 147.35M |
| Revenue (ttm) | 50.03M |
| Net Income (ttm) | 5.06M |
| Shares Out | 35.00M |
| EPS (ttm) | 0.14 |
| PE Ratio | 29.10 |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | April 19 |
| Last Price | $4.21 |
| Previous Close | $4.18 |
| Change ($) | 0.03 |
| Change (%) | 0.72% |
| Day's Open | 4.18 |
| Day's Range | 4.14 - 4.30 |
| Day's Volume | 23,159 |
| 52-Week Range | 4.10 - 22.00 |
Jiuquan, China, April 13, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announ...
Jiuquan, China, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announc...
Jiuquan, China, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announc...
New York, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, is a full-service investment bank and securities broker-dealer firm based in New York, today ...
Jiuquan, China, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (the “Company”) (Nasdaq: QLI), a China-based pharmaceutical and chemical products manufacturer, today announc...
Qilian (QLI) is catching the eyes of investors on Tuesday as shares of its stock started trading today via the company's IPO. The post Qilian IPO: 10 Things for Potential QLI Stock Investors to Know Abo...
Jiuquan, China, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announced the pricing...
About QLI
Qilian International is a pharmaceutical and chemical company based in China that focuses on the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (“TCMD”) product, heparin product, sausage casings, and fertilizers. We independently developed Gan Di Xin® and Ahan® Antibacterial Paste within our research and development department. Our products are sold in more than 20 provinces in China.
| Industry Drug Manufacturers-Specialty & Generic | IPO Date Jan 12, 2021 |
| CEO Zhanchang Xin | Employees 292 |
| Stock Exchange NASDAQ | Ticker Symbol QLI |
Financial Performance
In 2020, QLI's revenue was $50.03 million, an increase of 8.54% compared to the previous year's $46.10 million. Earnings were $5.06 million, a decrease of -5.04%.